TY  - JOUR
TI  - Comparison of Different Gemcitabine Formulations Regarding Cost-analysis and Duration of Exposure
AU  - KARAKOÇ, M.D.
JO  - Turk J Oncol
PY  - 2025
VL  - 40
SP  - 175
EP  - 181
DO  - 10.5505/tjo.2025.4562
ER  -